Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

3,749 public trials 1,059 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Active, Not Recruiting

Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer

NCT07448493

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +17 more
Locations
  • Gomel Regional Clinical Oncology Dispensary (OKOD) Homyel, Belarus
  • Kaliningrad Regional Clinical Oncology Center Kaliningrad, Russia
  • Moscow Regional Oncology Hospital No. 62 Krasnogorsk, Russia
  • A.S. Loginov Moscow Clinical Scientific Center Moscow, Russia
View all 15 locations
View Trial Details
Active, Not Recruiting

Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01

NCT06727565

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Siteman Cancer Center St Louis, Missouri, United States
  • Tennessee Oncology, PLLC - Greco-Hainsworth Centers for Research Nashville, Tennessee, United States
  • The University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • Westmead Hospital Sydney, New South Wales, Australia
View all 23 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

NCT05907304

Conditions
Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +34 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Florida Cancer Specialists - St. Petersburg St. Petersburg, Florida, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

NCT05438420

Conditions
Cervical Cancer, Digestive System Diseases, Digestive System Neoplasms, +25 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • CHA Bundang Medical Center Seongnam-si, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Active, Not Recruiting

Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer

NCT01893307

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Florida Health Science Center - Gainesville Gainesville, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

NCT04430738

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
View all 27 locations
View Trial Details

Related conditions